Items 441 to 450 of 465 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2R-Azido-1,4-dichloro-3S-butanol | sc-214092 | 100 mg | $380.00 | |||
2R-Azido-1,4-dichloro-3S-butanol serves as a chiral reagent, notable for its capacity to facilitate stereoselective reactions through unique steric and electronic effects. The presence of azido and dichloro groups introduces distinct reactivity patterns, allowing for selective nucleophilic attacks. Its chiral center enhances enantioselectivity, while the compound's ability to form stable complexes with transition states significantly influences reaction pathways, optimizing yields in asymmetric synthesis. | ||||||
(+)-(2S, 5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt | sc-214097 | 50 mg | $360.00 | |||
(+)-(2S, 5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt acts as a chiral reagent by promoting enantioselective transformations through its unique steric environment and hydrogen bonding capabilities. The piperazine ring introduces conformational flexibility, allowing for tailored interactions with substrates. Its camphoric acid salt form enhances solubility and stability, facilitating smoother reaction kinetics and improved selectivity in asymmetric synthesis, making it a versatile tool in chiral chemistry. | ||||||
(2S,4R)-3-Benzoyl-4-ethoxylcarbonylmethyl-4-methyl-5-oxazolidinone | sc-214102 | 250 mg | $380.00 | |||
(2S,4R)-3-Benzoyl-4-ethoxylcarbonylmethyl-4-methyl-5-oxazolidinone serves as a chiral reagent by leveraging its rigid oxazolidinone framework, which fosters specific stereochemical interactions. The presence of the benzoyl and ethoxycarbonyl groups enhances its ability to stabilize transition states, promoting enantioselectivity in reactions. Its unique spatial arrangement and electronic properties facilitate selective binding to substrates, optimizing reaction pathways and improving overall yields in asymmetric synthesis. | ||||||
NSC98948-d3 | sc-215589 | 1 mg | $330.00 | |||
NSC98948-d3 functions as a chiral reagent through its distinctive structural features that promote selective molecular interactions. The compound's unique stereogenic centers create a favorable environment for enantioselective reactions, enhancing the formation of specific diastereomers. Its ability to modulate reaction kinetics is attributed to the steric hindrance provided by its substituents, which influences the transition state and directs the course of asymmetric transformations effectively. | ||||||
3-Oxo-3-desvinylquinine 9-Acetate | sc-216535 | 10 mg | $300.00 | |||
3-Oxo-3-desvinylquinine 9-Acetate serves as a chiral reagent by leveraging its intricate molecular architecture, which facilitates specific interactions with substrates. The compound's unique arrangement of functional groups allows for enhanced selectivity in asymmetric synthesis, promoting the formation of desired enantiomers. Its reactivity is influenced by the electronic effects of its substituents, which can stabilize transition states and optimize reaction pathways, leading to improved yields in chiral transformations. | ||||||
5′(S)-Hydroxy Simvastatin | sc-217281 | 1 mg | $360.00 | |||
5'(S)-Hydroxy Simvastatin acts as a chiral reagent through its distinctive stereochemical configuration, which enables selective binding to chiral centers in substrates. The compound's hydroxyl group plays a crucial role in hydrogen bonding, enhancing its interaction with electrophiles. This interaction can modulate reaction kinetics, favoring specific pathways that yield enantiomerically enriched products. Its unique spatial arrangement also influences steric effects, further optimizing chiral synthesis. | ||||||
Annamycinol | sc-217654 | 500 µg | $540.00 | |||
Annamycinol serves as a chiral reagent characterized by its unique ability to form stable complexes with various substrates through non-covalent interactions. Its specific stereochemistry facilitates selective recognition of chiral centers, promoting asymmetric transformations. The compound's functional groups enhance dipole-dipole interactions, which can significantly influence reaction rates and pathways. Additionally, its conformational flexibility allows for dynamic adjustments during catalysis, optimizing enantioselectivity in synthetic processes. | ||||||
Ezetimibe Hydroxy tert-Butyldiphenylsilyl Ether | sc-218456 | 5 mg | $380.00 | |||
Ezetimibe Hydroxy tert-Butyldiphenylsilyl Ether acts as a chiral reagent, distinguished by its capacity to engage in intricate molecular interactions that enhance selectivity in asymmetric synthesis. Its bulky tert-butyldiphenylsilyl group provides steric hindrance, promoting unique spatial arrangements that favor specific reaction pathways. The compound's ability to stabilize transition states through hydrogen bonding and π-π stacking interactions further fine-tunes reaction kinetics, leading to improved enantioselectivity in various transformations. | ||||||
Ezetimibe Phenoxy tert-Butyldiphenylsilyl Ether | sc-218458 | 5 mg | $320.00 | |||
Ezetimibe Phenoxy tert-Butyldiphenylsilyl Ether serves as a chiral reagent, characterized by its unique ability to facilitate enantioselective reactions through specific steric and electronic effects. The presence of the phenoxy group enhances solubility and reactivity, allowing for selective interactions with substrates. Its structural features promote favorable conformations, while the silyl moiety aids in stabilizing reactive intermediates, ultimately influencing reaction dynamics and selectivity in asymmetric synthesis. | ||||||
Methyl (2R,3S)-2-Benzylamino-3-hydroxy-2-hydroxymethyl-4-methylpentanoate | sc-218714 | 25 mg | $330.00 | |||
Methyl (2R,3S)-2-Benzylamino-3-hydroxy-2-hydroxymethyl-4-methylpentanoate acts as a chiral reagent, distinguished by its capacity to induce enantioselectivity in various reactions. The presence of the benzylamino group introduces significant steric hindrance, which selectively influences substrate orientation. Additionally, the hydroxymethyl groups enhance hydrogen bonding interactions, promoting specific transition states that favor the formation of desired enantiomers, thereby optimizing reaction kinetics in asymmetric transformations. | ||||||